Cargando…
Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review
While the advent of immune-checkpoint inhibitors has revolutionized cancer therapy, immune-related adverse effects (irAEs) have also been on the rise. Cutaneous toxicities are among the most common irAEs, especially in the context of programmed cell death protein-1 (PD-1) inhibitors like pembrolizum...
Autores principales: | Madan, Vrinda, Marchitto, Mark C., Sunshine, Joel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443361/ https://www.ncbi.nlm.nih.gov/pubmed/37606485 http://dx.doi.org/10.3390/dermatopathology10030033 |
Ejemplares similares
-
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma
por: Kwon, Chase W., et al.
Publicado: (2020) -
Vulvar lichen planus pemphigoides()()
por: Loyal, J., et al.
Publicado: (2017) -
Narrowband UVB-induced lichen planus pemphigoide
por: Mandy Chan, Wai Man, et al.
Publicado: (2011) -
Methotrexate in Lichen Planus Pemphigoides – A Case Report and Review of the Literature
por: Dhir, Bhawuk, et al.
Publicado: (2023) -
Bullous Lichen Planus vs Lichen Planus Pemphigoides: A Diagnostic Dilemma
por: Tripathy, Durga M., et al.
Publicado: (2022)